Pharmaceutical Technology18 天
Calpurbatug by Trellis Bioscience for Gram-Positive Bacterial Infections: Likelihood of ...
The drug candidate is a broad-spectrum biofilm disruptor human monoclonal antibody. The drug candidate is developed based on the CellSpot technology. It is administered through intravenous, inhalation ...
Pharmaceutical Technology18 天
Calpurbatug by Trellis Bioscience for Prosthetic Joint infections: Likelihood of Approval
The drug candidate is a broad-spectrum biofilm disruptor human monoclonal antibody. The drug candidate is developed based on the CellSpot technology. It is administered through intravenous, inhalation ...